Last updated: May 5, 2026
Scope, Claims, and Patent Landscape for Croatia Drug Patent HRP20221150
What does Croatia drug patent HRP20221150 cover (scope)?
HRP20221150 is a Croatian patent publication under Croatia’s utility patent system (HR) for a drug-related invention. The available record content for HRP20221150 in the public domain is insufficient in the material provided to produce a complete, claim-by-claim, scope-accurate analysis of: (i) the exact therapeutic indication(s), (ii) the active pharmaceutical ingredient(s) (API), (iii) the pharmaceutical form(s), (iv) specific compounds/structures or salts, (v) dosage regimens, and (vi) the precise claim construction used by the examiner.
Because a complete and accurate scope analysis requires the actual published specification and the full set of claims for HRP20221150, and those claim texts are not present in the information supplied here, no precise claim mapping to product attributes, formulation, or dosing can be responsibly delivered.
What are the independent claim themes and claim-by-claim coverage?
A full “scope and claims” review requires the exact claim set (independent and dependent claims), including:
- Claim dependencies (which elements narrow which independent claim)
- Any Markush language or genus-definitions (compound classes, excipient lists)
- Any functional limitations (e.g., “inhibits,” “treats,” “improves,” “reduces” with specific readouts)
- Any structural definitions (formulae, substituent ranges)
- Any product-by-process limitations (if present)
- Any use claims (methods of treatment, Swiss-type format if applicable)
- Any process claims (manufacturing steps, reaction conditions)
The information provided here does not include the claim text for HRP20221150. Without that, a claim-by-claim breakdown would be incomplete or speculative, which violates the requirement for a complete and accurate response.
Where does HRP20221150 sit in the broader patent landscape (freedom-to-operate context)?
A credible patent landscape for a Croatia drug patent typically needs:
- Priority chain and family members (WO/EP/US/CN, PCT publication numbers)
- Legal status in Croatia (granted, lapsed, pending, withdrawn)
- Expiry dates and any patent term adjustments
- Whether the Croatian filing is a validated national phase or a separate filing
- Overlapping families around the same API (crystalline forms, polymorphs, salts, solvates, formulations, devices, dosing regimens, combination therapies)
None of these landscape anchors (publication family identifiers, priority dates, legal status, or related patents) are included in the information supplied here. Without them, any landscape mapping would be non-actionable and risks giving an incorrect clearance picture.
What does the Croatian system imply for claim enforceability and design-around routes?
Even without the exact claim texts, general Croatia utility-patent enforcement considerations typically involve:
- Claim scope defined by the published claims
- Potential narrowing by examination amendments
- Product infringement depending on claim category (product vs method of treatment)
- Use of dependent claims to create multiple enforceable “layers” if the claim set uses narrow dependencies
However, to translate these points into a specific, actionable view for HRP20221150, the actual claim formats are required (product claim vs method of treatment vs compound vs formulation vs use). The present input does not contain the claim formats or text.
Key Takeaways
- No complete claim or scope analysis is possible from the provided information for Croatia drug patent HRP20221150.
- A correct landscape requires the published claim set, the priority/family data, and legal status in Croatia. Those are not present in the material provided.
- Any attempt to list claim themes, compound/formulation coverage, or FTO overlap would be speculative and not suitable for high-stakes R&D or investment decisions.
FAQs
1) Can you summarize the independent claims of HRP20221150?
Not with the information provided. Independent-claim summaries require the actual published claim text.
2) Does HRP20221150 protect a specific active ingredient or a formulation?
The provided input does not include the patent’s specification or claims, so the scope category cannot be determined.
3) What is the likely expiry of HRP20221150 in Croatia?
Expiry depends on priority date and term computation, which are not included in the provided material.
4) What other countries likely have the same invention family as HRP20221150?
Family members cannot be identified without publication identifiers (WO/EP/US/etc.) and priority data.
5) What are the main design-around options for a generic or follow-on development?
Design-around routes depend on the exact claim elements (compound/formulation/formula/form functional limitations). The claim set is not provided here.
References
[1] Croatia patent publication HRP20221150 (exact bibliographic record, specification, and claim text not included in the provided input).
